These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 5674126

  • 1. Serum CPK in muscular dystrophy and myotonia dystrophica.
    Danowski TS, Sabeh G, Vester JW, Alley RA, Robbins TJ, Tsai CT, Pazirandeh M, Sekaran K.
    Metabolism; 1968 Sep; 17(9):808-17. PubMed ID: 5674126
    [No Abstract] [Full Text] [Related]

  • 2. Muscle creatine phosphokinase in primary myopathies.
    Vester JW, Sabeh G, Newton RH, Finkelhor HB, Fetterman GH, Danowski TS.
    Proc Soc Exp Biol Med; 1968 May; 128(1):5-8. PubMed ID: 5656716
    [No Abstract] [Full Text] [Related]

  • 3. Tabulation of findings in the muscular dystrophies and in myotonia dystrophica.
    Danowski TS, Wissinger HA, Hohmann TC, Gerneth JA, Folkers K, Vester JW, Fisher ER.
    Arch Phys Med Rehabil; 1971 May; 52(5):193-200. PubMed ID: 4931852
    [No Abstract] [Full Text] [Related]

  • 4. Serum pyruvate kinase in muscle disease and carrier states.
    Alberts MC, Samaha FJ.
    Neurology; 1974 May; 24(5):462-4. PubMed ID: 4857105
    [No Abstract] [Full Text] [Related]

  • 5. Creatine kinase isoenzymes in neuromuscular diseases.
    Somer H, Dubowitz V, Donner M.
    J Neurol Sci; 1976 Oct; 29(2-4):129-36. PubMed ID: 978205
    [Abstract] [Full Text] [Related]

  • 6. Creatine phosphokinase isozymes in neuromuscular disorders.
    Goto I.
    Arch Neurol; 1974 Aug; 31(2):116-9. PubMed ID: 4834973
    [No Abstract] [Full Text] [Related]

  • 7. Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy.
    Folkers K, Nakamura R, Littarru GP, Zellweger H, Brunkhorst JB, Williams CW, Langston JH.
    Proc Natl Acad Sci U S A; 1974 May; 71(5):2098-102. PubMed ID: 4525474
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Aldolase, GOT and LDH activity of the serum in progressive muscular dystrophy and myotonic dystrophy].
    CORRIDORI F, NEGRI S.
    Riv Sper Freniatr Med Leg Alien Ment; 1961 Mar 31; 85():161-9. PubMed ID: 13881467
    [No Abstract] [Full Text] [Related]

  • 10. The effect of hydrocortisone on the serum creatine kinase activity of muscles diseases.
    Cxyzewski K.
    J Neurol; 1977 Nov 01; 216(4):283-7. PubMed ID: 72811
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Family myotonic dystrophy with abnormally high levels of serum creatine phosphokinase (CPK)].
    Matsubara T, Hirose N, Yoshida S, Yamamoto T, Wada A.
    Rinsho Shinkeigaku; 1977 Apr 01; 17(4):217-23. PubMed ID: 328203
    [No Abstract] [Full Text] [Related]

  • 13. [Progressive muscle dystrophy. II. Enzyme activity chages in serum in progressive muscle dystrophy].
    Lujf A, Sluga E, Moser K.
    Wien Klin Wochenschr; 1971 Feb 19; 83(7):109-13. PubMed ID: 5547427
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cholinesterase and esterase activity in normal and dystrophic human muscle.
    Kar NC, Pearson CM.
    Biochem Med; 1973 Jun 19; 7(3):452-9. PubMed ID: 4515057
    [No Abstract] [Full Text] [Related]

  • 20. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K, Zatz M.
    Hum Hered; 1979 Jun 19; 29(3):154-60. PubMed ID: 468274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.